What molecular mechanisms link elevated sphingomyelin synthase activity to increased amyloid-beta generation?

PARTIALLY ADDRESSED

The study demonstrates that SGMS1 elevation correlates with increased Aβ and that SGMS inhibition reduces Aβ production, but the specific biochemical pathways connecting sphingomyelin metabolism to APP processing remain unexplained. Understanding this mechanism is critical for developing targeted therapeutic interventions. Gap type: unexplained_observation Source paper: Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation. (None, None, PMID:23977395)

Priority: 0.89 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What molecular mechanisms link elevated sphingomyelin synthase activity to increased amyloid-beta generation? is a 0.89 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What molecular mechanisms link elevated sphingomyelin synthase activity to increased amyloid-beta generation? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed
update on knowledge_gap by max_outlook1 2026-04-28T01:37
update on knowledge_gap by None 2026-04-25T22:15
update on knowledge_gap by None 2026-04-15T14:54
update on knowledge_gap by None 2026-04-15T14:54
update on knowledge_gap by max_gmail 2026-04-12T14:45
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps